Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04080492 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Cardiac Disease Quality of Life Study

Study acronym: UPLIFT
StatusTerminated
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial terminated Sponsor's reason: Enrollment goal not met Show 6 more changesShow less
    • Final enrollment: 380 participants (planned 1200)
    • Primary completion date changed from estimate of Dec 2026 to Sep 2, 2022
    • Study completion date changed from estimate of Dec 2026 to Sep 1, 2026
    • Study description revised
    • Site details revised
    • Eligibility criteria expanded, about 5 words
  2. Primary and study completion dates: Jun 2025 to Dec 2026
    • Site contact updated
    v7
  3. Primary completion date: Jun 2024 to Jun 2025
    • Study completion date: Mar 2025 to Jun 2025
    v6
  4. Primary completion date: Jun 2023 to Jun 2024
    • Study completion date: Mar 2024 to Mar 2025
    v5
  5. Primary endpoints: 25 to 9v4 Show 5 more changesShow less
    • Study completion date: Jun 2023 to Mar 2024
    • Eligibility criteria revised
    • Study description revised
    • Study arms: 2 to 3
    • Study title shortened, about 1 word
Show 2 earlier versionsHide 2 earlier versions
  1. Re-verified, no change to tracked fieldsv3
  2. Primary endpoints revised (25)
    • Eligibility criteria expanded, about 5 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective, longitudinal, non-comparator, non-randomized observational cohort study to assess the quality of life in adult patients affected by hypertrophic cardiomyopathy and thoracic aortic dilatations who are not amenable to surgery, as well as those affected radiation-induced cardiac disease caused by radiation therapy.
Trial Details
NCT Number NCT04080492
Lead Sponsor The Cleveland Clinic
Conditions
(from sponsor)		 Hypertrophic Obstructive Cardiomyopathy, Thoracic Aortic Dilatation, Heart Disease Caused by Ionising Radiation, Quality of Life
Related terms Cardiomyopathy, Hypertrophic
Enrollment 380 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov